Peter Hellemans
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
Papers in
- Oncology 20
- Peptidase Inhibition and Analysis 8
- HER2/EGFR in Cancer Research 7
-
- Protein Degradation and Inhibitors 8
- Histone Deacetylase Inhibitors Research 8
- Co-authors
- A.T. van Oosterom (3 shared papers)P. Buytaert (2 shared papers)Johan W. Smit (7 shared papers)Jan Gerris (4 shared papers)Eric Van Marck (1 shared paper)Joost Weyler (1 shared paper)Ronald de Vries (5 shared papers)Jan de Jong (11 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Blood (10 papers)Cancer Chemotherapy and Pharmacology (4 papers)Clinical Cancer Research (3 papers)European Journal of Obstetrics & Gynecology and Reproductive Biology (2 papers)
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
Peter Hellemans
56 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 88
- Genetics 373
- Hematology 265
- Pathology and Forensic Medicine 336
- Oncology 468
- Pharmacology 74
Countries citing papers authored by Peter Hellemans
This map shows the geographic impact of Peter Hellemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hellemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hellemans more than expected).
Fields of papers citing papers by Peter Hellemans
This network shows the impact of papers produced by Peter Hellemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hellemans. The network helps show where Peter Hellemans may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Hellemans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 199 | |
| 2 | 1995 | 174 | |
| 3 | 2013 | 103 | |
| 4 | 2019 | 84 | |
| 5 | 2015 | 82 | |
| 6 | 2015 | 71 | |
| 7 | 2015 | 63 | |
| 8 | 2015 | 62 | |
| 9 | 1995 | 62 | |
| 10 | 2016 | 53 | |
| 11 | 2020 | 42 | |
| 12 | 1991 | 36 | |
| 13 | 2018 | 34 | |
| 14 | 1995 | 29 | |
| 15 | 2016 | 27 | |
| 16 | 2020 | 25 | |
| 17 | 2017 | 24 | |
| 18 | 2017 | 24 | |
| 19 | 2018 | 22 | |
| 20 | 2016 | 21 |
About Peter Hellemans
Peter Hellemans is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Hematology and Genetics, having authored 57 papers that have together received 1.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Chronic Lymphocytic Leukemia Research (13 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Protein Degradation and Inhibitors (8 papers), Histone Deacetylase Inhibitors Research (8 papers), Peptidase Inhibition and Analysis (8 papers), HER2/EGFR in Cancer Research (7 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). The work is most often cited by research in Genetics (373 citations), Hematology (265 citations), Pathology and Forensic Medicine (336 citations), Oncology (468 citations) and Pharmacology (74 citations). Peter Hellemans has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include A.T. van Oosterom, P. Buytaert, Johan W. Smit, Jan Gerris, Eric Van Marck, Joost Weyler, Ronald de Vries, Jan de Jong, Juthamas Sukbuntherng and Nele Fourneau. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer Chemotherapy and Pharmacology, Clinical Cancer Research and European Journal of Obstetrics & Gynecology and Reproductive Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.